Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Follow us
04 Jan 2018
€15,200,000
Venture capital (Series A)
Boehringer Ingelheim Venture Fund, ParticipatieMaatschappij Vlaanderen, Merck Ventures BV, +2

| Belgian biotech company Rewind Therapeutics picks up Series A funding

PE HUB
04 Apr 2017

Venture Capital Access Online | Venture Capital News

vcaonline
+2
05 Jan 2017
€9,000,000
Venture capital (Series A)

HepaRegeniX Raises €9M in Series A Financing

FinSMEs
+1
14 Dec 2016

acousia Therapeutics Receives EUR 2 5 Million To Develop Innovative Therapy To Treat And Prevent Sensorineural Hearing Loss

biospace
+1
10 Apr 2016

STAT-Diagnostica secures EUR25m in Series C financing led by Gilde Healthcare\

Private Equity Wire
+1
04 Apr 2016

Metabomed Raises $18M in Series A Funding

FinSMEs
+2